Bromide

Bromide

SCHEMBL891051

Br.CCC(N)Br

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2215709 0.96
Hydrochloric Acid SCHEMBL28946239 0.92
SCHEMBL21974437 0.74
SCHEMBL29208153 0.74
Bromide SCHEMBL28990249 0.74
Bromide SCHEMBL7715175 0.73
Bromide SCHEMBL10976760 0.72
Bromide SCHEMBL31416096 0.70
Bromide SCHEMBL5277189 0.70
SCHEMBL2388357 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119861124-A NAD (P) modification method, immobilization method and continuous analysis sensor 三诺生物传感股份有限公司 2025-04-22 CN claimed
US-12460049-B2 Azide-functionalized copolymers SUSOS AG (CH) 2025-11-04 US disclosed
CN-119930598-A Non-reactive near-infrared mitochondrial cristae tracking super-resolution fluorescent probe and application thereof 山东大学 2025-05-06 CN disclosed
CN-119861124-A NAD (P) modification method, immobilization method and continuous analysis sensor 三诺生物传感股份有限公司 2025-04-22 CN disclosed
US-20250101177-A1 AZIDE-FUNCTIONALIZED COPOLYMERS SUSOS AG (CH) 2025-03-27 US disclosed
EP-4469503-B1 AZIDE-FUNCTIONALIZED COPOLYMERS SUSOS AG (CH) 2025-03-05 EP disclosed
EP-4469503-A1 AZIDE-FUNCTIONALIZED COPOLYMERS SuSoS AG (CH) 2024-12-04 EP disclosed
CN-115838495-B Self-supporting covalent cross-linking functional polyelectrolyte porous membrane and preparation method and application thereof 南开大学 2023-09-19 CN disclosed
WO-2023144228-A1 AZIDE-FUNCTIONALIZED COPOLYMERS SUSOS AG (CH) 2023-08-03 WO disclosed
CN-115991853-A Preparation of high specific surface accumulation ionic liquid carrier and immobilization of laccase by using same 北京理工大学 2023-04-21 CN disclosed
US-5153211-A Enzyme inhibitors ALCON LABORATORIES, INC. (US) 1992-10-06 US disclosed
EP-0294615-B1 CYCLOBUTENE-3,4-DIONE-INTERMEDIATES AND THEIR USE IN THE PREPARATION OF HISTAMINE H2-ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 1992-04-15 EP disclosed
US-5070100-A COMPLICATIONS OF DIABETES ALCON LABORATORIES, INC. (US) 1991-12-03 US disclosed
US-4927970-A Substituted 3-cyclobutene-1,2-dione intermediates BRISTOL-MYERS COMPANY (US) 1990-05-22 US disclosed
US-4864028-A ANTIDIABETIC AGENTS ALCON LABORATORIES, INC. (US) 1989-09-05 US disclosed
EP-0294615-A1 Cyclobutene-3,4-dione-intermediates and their use in the preparation of histamine h2-antagonists Bristol-Myers Squibb Company (US) 1988-12-14 EP disclosed
US-4717725-A SPIROCYCLIC AROMATIC IMIDES ALCON LABORATORIES, INC. (US) 1988-01-05 US disclosed
US-4537892-A ANTIDIABETIC AGENTS ALCON LABORATORIES, INC. (US) 1985-08-27 US disclosed
EP-0137333-A2 Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase ALCON LABORATORIES, INC. (US) 1985-04-17 EP disclosed
US-4470826-A HAIR DYES, NITRO DYES, DIRECT DYES L'OREAL (FR) 1984-09-11 US disclosed